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Abstract: 
Objectives:  Identifying drivers of complex traits from the noisy signals of genetic 
variation obtained from high throughput genome sequencing technologies is a 
central challenge faced by human geneticists today.  We hypothesize that the 
variants involved in complex diseases are likely to exhibit non-neutral 
evolutionary signatures.  Uncovering the evolutionary history of all variants is 
therefore of intrinsic interest for complex disease research.  However, doing so 
necessitates the simultaneous elucidation of the targets of natural selection and 
population-specific demographic history.  Methods: Here we characterize the 
action of natural selection operating across complex disease categories, and use 
population genetic simulations to evaluate the expected patterns of genetic 
variation in large samples.  We focus on populations that have experienced 
historical bottlenecks followed by explosive growth (consistent with most human 
populations), and describe the differences between evolutionarily deleterious 
mutations and those that are neutral.   Results:  Genes associated with several 
complex disease categories exhibit stronger signatures of purifying selection than 
non-disease genes.  In addition, loci identified through genome-wide association 
studies of complex traits also exhibit signatures consistent with being in regions 
recurrently targeted by purifying selection.  Through simulations, we show that 
population bottlenecks and rapid growth enables deleterious rare variants to 
persist at low frequencies just as long as neutral variants, but low frequency and 
common variants tend to be much younger than neutral variants.  This has 
resulted in a large proportion of modern-day rare alleles that have a deleterious 
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effect on function, and that potentially contribute to disease susceptibility. 
Conclusions: The key question for sequencing-based association studies of 
complex traits is how to distinguish between deleterious and benign genetic 
variation.  We used population genetic simulations to uncover patterns of genetic 
variation that distinguish these two categories, especially derived allele age, 
thereby providing inroads into novel methods for characterizing rare genetic 
variation driving complex diseases. 
 
Introduction: 
Over the last 12,000 years, humans have experienced explosive 
population growth, increasing in number by three orders of magnitude.  Such 
extreme growth has caused the dynamics of mutation accumulation and the 
distribution of allele frequencies to diverge significantly from the patterns 
expected at equilibrium.  Moreover, mutations arise every generation at a rate of 
1.1-3 ×10-8 per base in the human genome (1-3). Since there are ~3×109 bases 
in the human genome, we expect a given person to have, on average, between 
30-100 de novo mutations [consistent with observations in large family-based 
sequencing projects (1)].  With ~130M people born each year, it is estimated that 
every base in the human genome has the potential to mutate 1-4 times every 
year. Therefore, we expect every non-lethal mutation that is possible in the 
human genome to be present in numerous individuals throughout the world, and 
potentially on distinct haplotype backgrounds.   
Following the introduction of a germline mutation, the evolutionary forces 
of genetic drift and natural selection push the derived allele either towards loss 
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from the population, or towards increasing frequency and possible fixation.  If an 
allele is subject to natural selection, then large genomic areas can also be 
impacted due to genetic linkage.  In the case of strong positive selection, a 
region of the genome can be swept free of genetic variation. This scenario, 
referred to as a “selective sweep”, appears to have been rare in recent human 
evolution (4).  In the case of purifying selection, when deleterious alleles are 
recurrently purged from a locus, neutral variation in linked genomic 
neighborhoods can also be reduced. This much more common scenario is 
termed “background selection” (5, 6).  Signatures of both positive and negative 
selection have been identified throughout the human genome, but the relevance 
of identifying such signatures for genetic studies of human diseases has not 
been well studied. 
Characterizing how neutral and selective evolutionary processes have 
impacted modern day patterns of human genetic variation is an important step 
toward understanding the genetic drivers of disease.  However, this requires 
extremely large-scale sequencing data.  To date, thousands of human genomes 
(and thousands more exomes) have been sequenced (7-9).  These large-scale 
efforts have resulted in a flurry of discoveries about the patterns of genetic 
variation within and between human populations.  However, a mechanistic 
understanding about how the observed patterns of genetic variation impact 
human traits is still lacking. 
The sequencing of a small number of genes in more than ten thousand 
humans from a single population identified far more variants than previously 
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expected (10, 11).  Population genetic theory suggests that exploding human 
population growth will result in an accumulation of extremely rare variants. We 
hypothesize that some portion of this rare, potentially deleterious variation 
underlies much of the unexplained heritability of many complex traits (12).  
Recent sequencing of thousands of exomes from across the world 
revealed that the vast majority of genetic variation within genes is rare, arose 
recently, and is highly population-specific (7-9, 13).  Whole-genome sequencing 
of more than 1000 individuals from global populations has elucidated the broad-
scale patterns of genetic variation in much greater detail	  (7).  Such large-scale 
data suggest that human evolutionary history is more complex than originally 
thought (4). These observations are consistent with population genetic theory, 
and suggest that population genetics may be useful for elucidating the major 
genetic drivers of many complex diseases (14). 
The next phase of human genetic research will sequence ever-larger 
cohorts in order to pinpoint the genetic contributors to complex disease.  Such 
directions will undoubtedly identify an ever-increasing number of candidate 
variants that require follow-up. Population genetic theory may be of great utility 
for prioritizing candidate functional variants, thus allowing for a more efficient 
allocation of experimental resources.   
In this paper, we will demonstrate how population genetics can inform 
expectations about the nature of undiscovered disease-causing variants, and 
accelerate experimental discovery. In addition, we will show that the unique 
genetic signatures that we expect from deleterious alleles compared to other 
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variants may increase the power of statistical tests of association.  Although 
population genetic models have been developed for several decades to 
characterize the expected signatures of genetic variation driven by natural 
selection, such models have rarely been employed in genetic studies of complex 
disease [though see (15, 16)]. We will demonstrate that this is a promising 
avenue for future development.    
We will accomplish this through simulations, and through the analysis of 
genomic data. We begin our investigation by looking at negative selection across 
the exome. If complex disease-causing mutations were under the influence of 
natural selection, we would expect to observe evolutionary signatures in the 
genes harboring those variants, even in a sample of healthy individuals. Previous 
studies have identified evidence for stronger negative selection on Mendelian 
disease genes (17, 18), and noted a similar trend in candidate cis-regulatory 
regions of genes associated with complex diseases as a whole (18). Here, we 
extend these analyses to test for an enrichment of negative selection across 
genes associated with specific categories of complex diseases by analyzing 
resequencing data from the exomes of 20 European Americans and 19 African 
Americans (17, 18). Similarly, we also test for intensified background selection at 
loci previously associated with complex disease through GWAS.  
In addition, we perform extensive simulations of deleterious variation 
under a complex demographic model that incorporates recent explosive 
population growth to describe characteristic features of deleterious variation. 
Overall, our results demonstrate that population genetic approaches can 
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contribute greatly to the development of novel methods to identify causal genetic 
variation that contributes to disease. We expect that methods that integrate 
experimental data with population genetic theory will provide a great advantage 
in the hunt for the “missing heritability” of complex disease. 
 
Methods 
Disease association datasets 
 We used two disease association databases in this study, including the 
Genetic Association Database [GAD (19)] for our analysis of natural selection 
near genes associated with disease, and the catalog of GWAS targets published 
by the NHGRI (20) for our analysis of background selection at GWAS loci.  The 
latter set has also been annotated into specific disease/trait categories (21).  
These two resources enable complementary analyses, since the GAD provides a 
gene-centric view of complex disease including candidate genes, while the 
NHGRI GWAS catalog specifically focuses on genome-wide studies.  
 
Measuring natural selection on disease genes 
 Most classic statistical tests for natural selection are built on the idea of 
comparing two categories of mutations: those subject to natural selection (e.g., 
non-synonymous mutations) and those that are not (e.g., synonymous 
mutations).  From a population genetic perspective, the action of natural 
selection is mainly to increase or decrease the probability of a mutant allele 
becoming fixed in a population.  The McDonald-Kreitman (MK) Test (22) is a 
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powerful statistical test for natural selection that is based on this principle. This 
test compares the number of mutations that have become fixed between species 
to the number that are polymorphic within a population across synonymous and 
non-synonymous sites in a two-by-two contingency table. 
Torgerson et al. (18) developed a Bayesian extension of the MK test for 
estimating the probability that negative selection was operating on each gene in 
the genome for both coding regions (CDS; comparing non-synonymous and 
synonymous sites) and conserved non-coding regions (CNC; comparing CNC 
sites to synonymous sites).  The approach was applied to exome sequence data 
from 20 European American individuals and 19 African American individuals, and 
we used their results in our study.   
We applied a Mann-Whitney U test to compare the distribution of the 
probability of negative selection in genes associated with 17 classes of complex 
disease from the Genetic Association Database (19) to the distribution of genes 
not previously associated with complex disease.  We then perform a binomial 
test to evaluate whether there is an enrichment of significant tests at a nominal 
level of p<0.05 for each population and sequence annotation (CDS versus 
CNCs), in which we used 0.05 as our theoretical probability of success and the 
total number of complex disease/trait categories that fell into each bin of Table 1. 
 
Background Selection Scores 
 Diversity at a neutral locus can be reduced by selection acting at 
genetically linked loci in a process referred to as background selection (4-6, 23-
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26).  The effect of background selection was recently inferred for each base of 
the human genome (25).  We transformed the scores, B, to range from 0 (no 
effect of background selection) to 1 (diversity completely reduced due to 
background selection).  Fractional values between zero and one represent the 
relative reduction in diversity due to background selection, compared to what is 
expected at a neutral locus (e.g., B=0.5 indicates that background selection has 
reduced diversity by 50%).  For each GWAS SNP, we extracted the B score from 
(25), the allele frequency in the CEU population of HapMap, and the genetic 
distance to the nearest gene in hg19.   
 
Choosing control SNPs for GWAS analysis 
One thousand sets of control SNPs were chosen via rejection sampling. 
Each set was matched in distribution to GWAS SNPs based on allele frequency, 
and in the case of intergenic SNPs, genetic distance to the nearest gene. Allele 
frequencies were taken as the CEU HapMap frequency, and for each GWAS 
SNP, a centered window of 0.25cM was excluded from sampling. Average 
background selection scores were then calculated for each base in the control 
set.  We then generated a quantile-quantile plot of the effect of background 
selection at GWAS loci versus the expected effect of background selection given 
our control sets (taken as the mean of the order statistics across the 1000 sets).  
A confidence interval was estimated as the entire range of the order statistics 
across all 1000 sets.   
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Diversity versus phyloP  
PhyloP scores are a measure of evolutionary conservation generated from 
a multispecies alignment. For our study, we used an alignment of 46 placental 
mammals (27).  Positive phyloP scores indicate conservation across species 
while negative values indicate rapid evolution across species.  PhyloP scores 
were obtained from the UCSC genome browser 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/phyloP46way/).  We 
calculated per site diversity for CEU, YRI and CHB in the 1000 Genomes Project 
Phase I data set (7).  Diversity was calculated as 2p (1 - p) N/(N-1), where p is 
the allele frequency and N is the number of chromosomes sequenced in the 
population.  We have previously shown that, despite the low coverage nature of 
the genome-wide sequencing data set, this estimator accurately recapitulates 
diversity when a sufficient number of sites are included in the calculation (4).  
Sites across the genome with similar phyloP scores were binned in intervals of 
0.08, and mean diversity was calculated for each bin. The data were fit to a linear 
model relating log(π) ~ phyloP.  Only sites with phyloP scores between -1.2 and 
1.2 were used to fit the model, and the regression line was extrapolated across 
the full range of phyloP scores (-4, 3). 
 
Distribution of selection coefficients 
Natural selection acts to increase the probability that advantageous 
mutations increase in frequency, while constraining the frequency of deleterious 
mutations.  In this study, we were primarily concerned with the effects of 
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deleterious mutations.  For the simulations discussed below, we used the 
distribution of selection coefficients inferred previously from an exome-scale 
sequence data set (28).  The parameters for the distribution of selection 
coefficients were inferred for both European Americans as well as African 
Americans, and the results were largely concordant.  We therefore incorporated 
the previously published distribution directly, which is highly leptokurtic with: -s ~ 
Γ(0.184, 0.00040244).  Note that we only consider deleterious selection 
coefficients (s<0), and will sometimes report the absolute value of the selection 
coefficient for convenience.  Also note that the same individuals that were used 
to estimate the distribution of selection coefficients were also used to measure 
the probability of natural selection acting on disease versus non-disease genes 
above. 
 
Demographic history 
We used the demographic history inferred from exome data sequenced 
across 2,440 samples from two populations (9).  This model incorporates the 
demographic history of both a European and African population.  Our simulations 
were focused on a European demographic model, but are relevant for all 
populations that have experienced historical bottlenecks and recent growth.  We 
focused on this population, as the vast majority of GWAS findings are from 
European populations (29), and for the most part it remains to be seen whether 
the same loci are associated in non-European populations.  
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Extracting the European demographic history from the two-population 
model may lead to systematic differences in the allele frequency spectrum due to 
the absence of historical migration.  However, such events are unlikely to 
substantially contribute to rare genetic variation, as recent migration rates are low 
and the age of rare variants is too short to have arisen prior to the Out Of Africa 
event.  The demographic history included an ancient African expansion 
(~177kya), an out-of-Africa bottleneck (~62kya), a founding of Europe bottleneck 
(~28kya), an initial phase of exponential growth within Europe, and a recent 
explosive growth phase (starting ~5kya). 
 
Simulations 
All simulations were performed using SFS_CODE (30).  This is a flexible 
forward time population genetic simulator that is capable of handling arbitrarily 
complex demographic histories and distributions of selection coefficients. We 
performed 106 simulations of a gene of length 1500bp, including the model of 
human demographic history and distribution of selection coefficients operating on 
non-synonymous mutations (discussed above).  At the beginning of each 
simulation, a random nucleotide sequence was generated, and a population with 
2,000 diploid individuals was created.  Random mating occurred for a burn-in 
period of 20,000 generations to reach mutation-selection balance, at which point 
the demographic model ensued.  We then sampled 5,000 diploid individuals 
(drawn from the terminal population of size 140,086 individuals).  Each 
generation consisted of random mating between males and females, with a 
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Poisson number of new mutations entering the population each generation (with 
mean θ/2=0.0005 per base).  Generations were converted to years by rescaling 
to the ancestral population size	  of 7310 [inferred by (13)] and assuming 30 years 
per generation.  A smaller number of simulations were performed using the 
ancestral size of 7310 individuals inferred by (13), with completely concordant 
results [as expected since the relevant parameters are scaled by the effective 
population size; see SFS_CODE user manual for longer discussion on this topic 
(30)].  A representative SFS_CODE command line is as follows:  sfs_code 1 
1 -A -n 5000 -N 2000 -L 1 1500 -I -r 0.001 -W 2 0 0 0 0.184 
0.00040244 -Td 0 1.98 -Td 0.264196 0.12859 -Tg 0.340566 
44.75089 -Td 0.340566 0.554513 -Tg 0.39085 282.7192 -TE 
0.404845. 
 
Results 
Natural selection in regions associated with complex traits 
By analyzing the exomes of 20 individuals from two populations 
(European American and African American), we find that genes associated with 
six categories of complex traits are enriched for signatures of negative selection.  
These include cancer, cardiovascular, developmental, metabolic, and 
pharmacogenomic traits (Table S1).  The number of disease categories that are 
significant at the 0.05 level are shown in Table 1, with a binomial p-value 
suggesting an enrichment of negative selection in coding (CDS) regions for both 
European and African Americans, and in conserved non-coding (CNC) regions 
only in European Americans for genes associated with complex traits.  This 
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suggests that negative selection inferred from population-based samples may be 
useful for disentangling the genetic basis of complex traits. 
Natural selection acting on specific loci throughout the human genome 
also impacts patterns of genetic diversity in genetically linked regions through an 
effect known as background selection (5, 6, 23-26).  We find that the loci that 
have been significantly associated with complex traits [as identified in the 
National Human Genome Research Institutes catalog of genome-wide 
association studies	  (20)] show elevated levels of background selection compared 
to 1000 control sets of SNPs (each set having the same number of SNPs, allele 
frequency distribution, and genetic distance to nearest coding gene as the 
GWAS hits). In Figure 1, we show a quantile-quantile (QQ) plot of the effect of 
background selection across GWAS SNPs versus the expected effect of 
background selection at control loci (with the full range of B scores for each 
quantile across all 1000 control sets shown in pink).  Using a Mann-Whitney U 
test to compare the distribution of B scores for GWAS SNPs versus B scores for 
control SNPs confirms the visual presentation in Figure 1 (p=1.4×10-138). 
To evaluate whether the enriched signature of background selection was 
due to particular types of diseases, we performed the same analysis for loci 
associated with each of 15 complex diseases and traits (21).  Figure S1 shows 
QQ-plots for each disease category, which demonstrates that the enrichment of 
background selection for GWAS hits is most extreme for seven categories, 
though all but two [parasitic bacterial disease (N=27) and viral disease (N=99)] 
are suggestive. 
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In summary, genes associated with complex diseases and traits are 
enriched for signatures of negative selection, and genomic loci associated with 
complex diseases and traits exhibit increased levels of background selection.  
Together, this suggests that directly utilizing signatures of natural selection can 
aid in discovering novel loci associated with complex disease.  
 
Long-term evolutionary trends and patterns of diversity 
In addition to patterns of diversity within human populations, long-term 
signatures of natural selection can also be obtained by analyzing the genomes of 
distantly related species (27).  This information can be used in tandem with 
population genetic signatures to better identify targets under selection.  In Figure 
2, we correlate diversity with phyloP [a measure of evolutionary conservation with 
positive values indicating higher conservation (27)].  While long-term evolutionary 
constraint likely contributes to this correlation, a regression model fit using only 
neutral values (phyloP between -1.2 and 1.2) and extrapolated to extreme values 
yields decent performance in predicting the levels of diversity in the most highly 
constrained regions of the genome (phyloP > 2; though there is an excess of 
diversity observed across populations) as well as in the most quickly evolving 
regions of the genome (phyloP < -2).   
We then compared the distribution of phyloP scores at the GWAS SNPs 
discussed above to sets of control SNPs.  In contrast to a previous comparison 
that did not account for frequency or genetic distance to genes (31), we find no 
statistical difference between the two matched groups using a Mann-Whitney U 
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test (p=0.052).  This suggests that GWAS SNPs are likely not causal, but, rather, 
are genetically linked to the causal allele (concordant with our observation of 
highly enriched signature of background selection around GWAS SNPs).  
 
The impact of natural selection and demography on rare variation 
Natural selection acts to increase the probability that adaptive mutations 
will rise in frequency and that deleterious mutations will decrease in frequency.  
Demographic effects simply modulate the variance in allele frequency change 
over generations with no bias toward increasing or decreasing frequency.  
However, when acting simultaneously, deleterious alleles can sometimes rise in 
frequency (32).  We used simulations to better understand the composition of 
fitness effects acting on variants across the frequency spectrum.  In Figure 3, we 
show simulation results using SFS_CODE (30) that demonstrate the distribution 
of fitness effects for variants in several frequency ranges (see Methods for 
details). While over 30% of all variants that were private to a single chromosome 
out of a sample of 10,000 chromosomes (5,000 individuals) were moderately to 
strongly deleterious, only a small fraction of variants with frequency >5% had 
moderately negative fitness effects.  Importantly, variants with frequency >10% 
had only weak fitness effects.   
In addition to having a wide range of fitness effects, variants that have the 
same frequency can also have a very broad distribution of ages (i.e., the time 
since the derived mutant allele arose in the population). The shape of the 
distribution of ages has a critical relationship with the population’s demographic 
	   17	  
history.  The demographic history we use is shown in the background of Figure 4 
(left axis), which incorporates an ancient expansion, an out-of-Africa bottleneck, 
a founding-of-Europe bottleneck, and two phases of exponential growth (an 
early, slower phase, and a more recent explosive growth phase; see Methods). 
Figure 4 also shows violin plots for the ages of non-synonymous mutations in 
various frequency ranges (singletons, doubletons, <0.01%, etc.; right axis).   
Consistent with previous observations (13), we find for these simulations 
that essentially all non-synonymous variants that are <1% frequency will have a 
negligible probability of being old enough to be shared across continents without 
requiring high rates of migration (i.e., they have arisen since the founding-of-
Europe bottleneck). This has profound implications for studying the genetics of 
complex traits across populations, since if rare variants are a predominant source 
of the heritability of complex traits, then we will be unlikely to replicate many 
associations across populations.  However, we find that even for those mutations 
that are incredibly rare (e.g., private to a single chromosome out of 10,000), there 
can still be a surprisingly broad range of ages, with 9% of these variants being 
greater than 3,000 years old.   
 
The age distribution of deleterious versus neutral variants 
Identifying methods for distinguishing variants with strong effects from 
those with weak effects is critically important.  A classic result in population 
genetics suggests that for variants at the same population frequency, deleterious 
alleles will on average be younger than neutral alleles [i.e., mutant alleles driven 
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by natural selection will have arisen more recently in the past (33)].  This result 
suggests that if we were able to accurately estimate the ages of mutations across 
the genome, then we would be able to distinguish deleterious alleles from neutral 
ones at the same frequency.  To evaluate this hypothesis, we rely on simulations 
where the true age of an allele is known.  
In Figure 5 we show the average age of variants in four fitness effect 
classes across a range of allele frequencies.  Note that synonymous variants are 
neutral, and non-synonymous variants are only exposed to deleterious fitness 
effects so only the absolute value of the selection coefficient is shown.  We find 
no distinction in the average age of variants that are synonymous, nearly neutral, 
or even weakly deleterious for any frequency range.  In contrast, there is a clear 
reduction in the average age of the most deleterious variants for common alleles 
(>1%), and a moderate reduction in age for the low-frequency variants (0.5%-
1%) and singleton class (Figure 5).   
Since strongly deleterious alleles are on average younger than neutral 
alleles for low frequency and common variants, we next set out to characterize 
the distribution of ages for these two categories.  Figure 6 shows the average 
age for neutral (blue; s> -10-5) and strongly deleterious (red; s< -10-2) mutations 
as a function of allele frequency.  Each curve is contained in an envelope 
representing the 90% quantile range of all variants observed at that frequency.  
We find a marked difference in the average age of deleterious and nearly neutral 
variants that have frequency >1%.  The inset in Figure 6 zooms into the <2% 
allele frequency range, where it is apparent that after 0.5% frequency, the age 
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distribution of neutral alleles starts to widen.  While the age distribution of 
deleterious variants is largely contained within the distribution of neutral variants, 
it is clear that a large fraction of neutral variants could potentially be identified 
based on their age (and therefore eliminated from further follow-up). 
 
Discussion 
Natural selection is the evolutionary force that acts to either increase or 
decrease the frequency of a genetic variant based on its effect on reproductive 
fitness. The effects of natural selection are amplified by demographic changes, 
with the strength of selection being proportional to population size (28, 34, 35).  
For example, selection has a much weaker effect on allele frequency in smaller 
populations.  
We find that genes associated with several complex disease/trait 
categories display an excess of negative selection, even in healthy individuals 
(Tables 1 and S1).  It is plausible that the disease-associated genes showing 
most evidence for negative selection would also contain a greater excess of rare 
variants, particularly in patients with the associated disease.  In an application of 
this hypothesis, nine of the asthma-associated genes showing the strongest 
signatures of negative selection were sequenced in 450 asthmatic cases and 515 
controls from two populations (36).  Multiple genes were found to exhibit an 
excess of rare variants in cases compared to controls.  Broader sequencing 
efforts are underway to fully evaluate the usefulness of natural selection as a 
predictor of functionally relevant patterns of genetic variation. 
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More broadly, we observe that genomic loci associated with complex 
diseases and traits through GWAS exhibit enriched signals of background 
selection compared to control SNPs (Figure 1).  This implies that GWAS SNPs 
tend to be located in regions of the genome that are surrounded by loci that are 
recurrent targets of negative selection.  Yet, we find that the SNPs so far 
identified do not exhibit greater evolutionary constraint than control SNPs.  This 
suggests that targeted sequencing studies around GWAS hits in large samples 
could be fruitful in discovering causal rare variants. 
While GWAS SNPs themselves are not enriched for greater evolutionary 
constraint, we do observe that genetic diversity across three human populations 
is highly correlated with long-term evolutionary constraint (Figure 2).  However, it 
remains unclear how much of this correlation is due to ongoing negative 
selection as opposed to complex patterns of neutral variation.  It was previously 
shown that some of the correlation between conservation and diversity is innate 
to neutral evolutionary processes, and can be recapitulated in neutral simulations 
that by chance have lower divergence	  (37).  Nonetheless, regions of the genome 
with the highest level of evolutionary conservation have been found to exhibit 
greater evidence of negative selection than predicted by neutral evolutionary 
models (37). We do not replicate this result, as we find slightly higher levels of 
diversity in regions with extremely large phyloP scores (i.e. highly conserved 
regions) than we predicted based on an extrapolation of the correlation between 
diversity and divergence that was observed in nearly neutral regions of the 
genome.  At least part of this can be explained by changes in the fitness 
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landscape in recent human evolution, whereby some highly conserved regions 
have become extremely rapidly evolving (38). 
Another complication is that the complex demographic history of many 
human populations (multiple bottlenecks followed by recent explosive growth) 
has radically shaped patterns of genetic diversity across the genome.  During 
historical bottlenecks, deleterious mutations were tolerated more readily, allowing 
them to segregate at slightly higher frequencies [and resulting in increased 
homozygosity of deleterious mutations in some populations compared to others 
(32)].   The explosive growth that humans have experienced over the last ~5,000 
years is again reshaping the landscape of natural selection in human 
populations.   
One consequence of the action of natural selection is that most of the 
strongly deleterious variants are purged from the population before they reach 
0.1% frequency (Figure 3).  If effect sizes of causal variants for complex disease 
are correlated with fitness effects, then this is a population genetic justification for 
studying rare genetic variation across very large population samples. That is, 
common variation is largely neutral and unlikely to harbor functionally relevant 
variation. This agrees with many GWAS that have found common variants to 
generally have very small effect sizes.  Having accepted the importance of rare 
variation, however, the key question then becomes how to distinguish 
functionally relevant variants (which are likely deleterious) from those that are 
neutral and ostensibly extraneous.  
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In Figure 6, we describe the variation in the ages of neutral and strongly 
deleterious alleles.  We find marked differences in the distributions of alleles that 
have frequency >0.5%. The primary observation is that neutral alleles tend to 
have a considerably wider distribution of allele ages compared to deleterious 
alleles, which have a remarkably small variance in age across the entire allele 
frequency range.  This observation suggests a simple criterion for prioritizing 
variants to be functionally characterized: all else being equal, the youngest 
alleles in each frequency range should be examined first.   
A recent publication described the ages of alleles observed in sample of 
>6000 exomes (8).  They point out that the variants that are identified as 
deleterious by multiple methods tend to be younger on average than predicted 
neutral variants.  However, the method used to date the age of each mutation 
was based solely on allele frequency, similar to our presentation in Figure 4.  
One implication is that such a method would not predict a difference in allele age 
for neutral and deleterious variants at any given frequency (such as we observe 
in Figure 5).  This emphasizes the need for novel methods that utilize more 
information, such as haplotype lengths and population sharing, for characterizing 
the ages of alleles. 
Nonetheless, population geneticists will still face challenges when 
developing methods that classify variants as deleterious or neutral, at least for 
the class of rare variants that are potentially of most interest for large-scale 
genome sequencing efforts of complex diseases (0.02%-0.5% frequency).  In 
contrast to more common variants (>0.5% frequency), there is no difference in 
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the average age across any fitness class (Figure 5). This counterintuitive result 
appears to be at odds with population genetic theory (33), but is a result of the 
substantial—and frequently neglected—impact of a complex demographic 
history.  It has previously been shown that population bottlenecks can increase 
the relative proportion of deleterious variants compared to populations that have 
not experienced a previous bottleneck (32).  Moreover, a previous simulation 
study found that strongly deleterious variants at 1% frequency were no younger 
than neutral variants in an extremely rapidly growing population (39).  It is 
therefore imperative that further studies exhaustively evaluate the population 
characteristics of rare deleterious variants to provide insight into what 
distinguishes them from neutral variants. 
Among low frequency and common variants (i.e., >0.5% frequency), 
deleterious alleles are on average younger than neutral alleles. As a result, we 
expect that these two classes of variants will exhibit very different patterns of 
haplotype lengths.  While the simulations performed in this study are not 
sufficient to characterize the distribution of haplotype lengths (which requires the 
simulation of sequences much longer than 1.5kb), we would expect younger 
alleles to reside on longer haplotypes.  The length of a haplotype is directly 
related to our ability to accurately impute missing data on that haplotype	  (40), 
which implies that if deleterious alleles are indeed younger on average than 
neutral variants, then we would expect to have much greater power to accurately 
impute them.   
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 Increased sequencing efforts will be indispensible for elucidating the role 
of rare variation in diseases and complex traits.  As the field of human genetics 
progresses toward the sequencing of more and more human genomes, thorough 
analyses of genome diversity will continue to be imperative.  We suggest that a 
careful consideration of the evolutionary processes that shape human genetic 
variation should play an important role in illuminating the genetic basis of human 
phenotypic variation.  By combining information from multiple sources and 
statistical techniques developed across multiple fields, the future is bright for 
uncovering the genetic architecture of complex traits. 
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Tables:   
 
 
Table 1:  Negative selection operates on genes and conserved non-coding 
(CNCs) regions near genes that are associated with complex diseases.  Each 
cell contains the number of complex disease categories (out of 17) with 
statistically more negative selection compared to background (and binomial-
based p-value for enrichment given the number of diseases tested at the 5% 
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significance level). 
 
 
 
 
 
 
  
 AA CA Pooled 
CDS 3 (0.009) 2 (0.05) 5 (0.006) 
CNCs 1 (0.21) 3 (0.009) 4 (0.03) 
Pooled 4 (0.026) 5 (0.006) 9 (0.002) 
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FIGURE LEGENDS:  
 
 
Figure 1.  GWAS SNPs for complex traits are significantly more impacted by 
background selection than are control SNPs in HapMap (41) (chosen to match 
the frequency and genetic distance to closest gene of GWAS SNPs).  In blue is a 
QQ-plot comparing the background selection scores for GWAS quantiles versus 
the background selection score for control SNPs.  In pink is the entire range of 
background scores for each quantile across 1000 independently drawn control 
sets.  
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Figure 2: There is a strong log-linear correlation between genetic diversity within 
three human populations [π; (7)] and long-term evolutionary conservation across 
species [phyloP (42)].  Regression lines for each population have been fit to the 
subset of data considered neutral (phyloP between -1.2 and 1.2), and 
extrapolated to the range of data observed across the genome. 
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Figure 3.  The distribution of selection coefficients for variants in each allele 
frequency bin (starting with singletons, doubletons, and then a disjoint partition of 
rare and common variants).  Common variants (>5%) are expected to be 
primarily neutral or nearly-neutral.  Most strongly deleterious mutations are 
<0.1% frequency.   
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Figure 4.  Simulations demonstrate that the patterns of genetic variation of 
European populations have been shaped by a complex demographic history and 
distribution of deleterious selective effects.  This violin plot shows the distribution 
of ages of non-synonymous mutations for each allele frequency bin (right axis, 
including singletons and doubletons, followed by a partitioning of rare variant 
frequencies), overlaid on top of a model of European demographic history (9) 
(grey, with relative population size on left axis).  
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Figure 5.  The average age of mutations in various frequency bins, partitioned 
into synonymous variants, neutral non-synonymous variants (|s|<10-5), weakly 
deleterious variants (10-4<|s|<10-3), and strongly deleterious variants (|s|>10-2).  
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Figure 6.  Deleterious alleles are younger on average than neutral alleles at the 
same frequency.  Solid curves represent mean age of alleles at each frequency 
for non-synonymous variants that are neutral (blue) and strongly deleterious 
(red).  The pink and blue envelopes show the 90%-quantile range of ages for all 
variants observed at each frequency.  Inset is a zoom into the low frequency 
range showing the increased variance in age for neutral variants at frequency 
>0.5%.  Variants at higher frequencies have been pooled such that the mean and 
90%-quantile range are based on at least 200 variants.  Curves are smoothed 
with loess using a span of 0.1. 
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SUPPLEMENTAL	  
 
Table S1: Negative selection on disease categories.  Each disease category is 
represented by four lines of data.  Each line has the population (African 
American/European American), annotation (conserved non-coding [CNC]/coding 
sequence [CDS]), the number of genes associated with that disease category for 
which we have data, the number of genes excluding all disease categories for 
which we have data, the mean probability of negative selection across genes 
associated with the disease category, the mean probability of negative selection 
across genes excluding all disease categories, and the Mann-Whitney U p-value 
comparing the distributions of the probability of negative selection across genes 
associated with the disease category versus other genes.  P-values that are 
significant at the 0.05 level are in bold. 
 pop data #Assoc. Other meanAssoc meanOther p-value 
Aging AA CNC 24 7388 0.3265958 0.3237955 0.2325 
AA CDS 23 6358 0.5557435 0.5191416 0.1582 
CA CNC 24 7155 0.3305875 0.329751 0.2628 
CA CDS 25 6160 0.611008 0.5676958 0.1655 
Cancer AA CNC 173 7388 0.3394023 0.3237955 0.04529 
AA CDS 179 6358 0.5228251 0.5191416 0.4443 
CA CNC 167 7155 0.3636581 0.329751 0.00352 
CA CDS 180 6160 0.5773372 0.5676958 0.298 
Cardiovascular AA CNC 201 7388 0.3282109 0.3237955 0.358 
AA CDS 219 6358 0.549905 0.5191416 0.02862 
CA CNC 193 7155 0.3330347 0.329751 0.5163 
CA CDS 220 6160 0.5893723 0.5676958 0.09786 
Chemical 
Dependency 
AA CNC 41 7388 0.3458439 0.3237955 0.109 
AA CDS 30 6358 0.4423467 0.5191416 0.9755 
CA CNC 38 7155 0.3224895 0.329751 0.4995 
CA CDS 31 6160 0.5411226 0.5676958 0.766 
Developmental AA CNC 48 7388 0.3366521 0.3237955 0.1805 
AA CDS 38 6358 0.5402158 0.5191416 0.2671 
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CA CNC 47 7155 0.3592085 0.329751 0.1082 
CA CDS 42 6160 0.6416595 0.5676958 0.00902 
Hematological AA CNC 24 7388 0.3427 0.3237955 0.09617 
AA CDS 32 6358 0.46665 0.5191416 0.9219 
CA CNC 20 7155 0.316215 0.329751 0.8341 
CA CDS 31 6160 0.4790323 0.5676958 0.9956 
Immune AA CNC 169 7388 0.3211533 0.3237955 0.3441 
AA CDS 198 6358 0.5317793 0.5191416 0.1912 
CA CNC 165 7155 0.3414776 0.329751 0.05543 
CA CDS 192 6160 0.5686474 0.5676958 0.5519 
Infection AA CNC 49 7388 0.3055 0.3237955 0.574 
AA CDS 64 6358 0.5347484 0.5191416 0.303 
CA CNC 49 7155 0.3555531 0.329751 0.07868 
CA CDS 61 6160 0.5717836 0.5676958 0.5154 
Metabolic AA CNC 237 7388 0.3333046 0.3237955 0.1513 
AA CDS 249 6358 0.5379739 0.5191416 0.04641 
CA CNC 231 7155 0.3581805 0.329751 0.0161 
CA CDS 245 6160 0.5910837 0.5676958 0.03799 
Neurological AA CNC 120 7388 0.3113 0.3237955 0.8659 
AA CDS 100 6358 0.518476 0.5191416 0.5738 
CA CNC 113 7155 0.3291496 0.329751 0.6071 
CA CDS 97 6160 0.5722299 0.5676958 0.5123 
Other AA CNC 219 7388 0.3244265 0.3237955 0.4513 
AA CDS 225 6358 0.5389133 0.5191416 0.04889 
CA CNC 206 7155 0.3275316 0.329751 0.3597 
CA CDS 219 6160 0.5750078 0.5676958 0.2851 
Pharmacogenomic AA CNC 56 7388 0.3357036 0.3237955 0.2611 
AA CDS 58 6358 0.5280845 0.5191416 0.3902 
CA CNC 50 7155 0.368852 0.329751 0.01569 
CA CDS 57 6160 0.5720702 0.5676958 0.496 
Psychological AA CNC 153 7388 0.3149144 0.3237955 0.6817 
AA CDS 112 6358 0.526833 0.5191416 0.3743 
CA CNC 151 7155 0.3359338 0.329751 0.4872 
CA CDS 116 6160 0.5834086 0.5676958 0.3154 
Renal AA CNC 57 7388 0.3331719 0.3237955 0.1028 
AA CDS 68 6358 0.5224221 0.5191416 0.4384 
CA CNC 54 7155 0.3232741 0.329751 0.5621 
CA CDS 66 6160 0.5691076 0.5676958 0.436 
Reproduction AA CNC 57 7388 0.3228404 0.3237955 0.1809 
AA CDS 69 6358 0.5317464 0.5191416 0.3314 
CA CNC 56 7155 0.3540446 0.329751 0.1071 
CA CDS 68 6160 0.5800721 0.5676958 0.3279 
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Unknown AA CNC 47 7388 0.3103128 0.3237955 0.5766 
AA CDS 46 6358 0.5116196 0.5191416 0.6982 
CA CNC 43 7155 0.3425163 0.329751 0.1793 
CA CDS 49 6160 0.5850857 0.5676958 0.3852 
Vision AA CNC 32 7388 0.3017906 0.3237955 0.6987 
AA CDS 36 6358 0.4809944 0.5191416 0.8748 
CA CNC 30 7155 0.33131 0.329751 0.3997 
CA CDS 37 6160 0.5669081 0.5676958 0.5373 
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Figure S1. QQ-plots for the effect of background selection in each of 15 complex 
disease and trait categories (and overall).  For each panel, an independent set of 
1000 controls sets of SNPs were created to reflect the number of SNPs 
associated with that particular category as well as the frequency of those alleles 
and their distance to nearest gene.  To provide even smoothness across sample 
sizes, we have discretized the plot into five percentile intervals (vigintiles).  
 	  
